BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17123820)

  • 1. Synthesis of 11C-labelled (R)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET.
    Schou M; Pike VW; Sóvágó J; Gulyás B; Gallagher PT; Dobson DR; Walter MW; Rudyk H; Farde L; Halldin C
    Bioorg Med Chem; 2007 Jan; 15(2):616-25. PubMed ID: 17123820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the metabolites of (S,S)-[(11)C]MeNER in humans, monkeys and rats.
    Schou M; Zoghbi SS; Shetty HU; Shchukin E; Liow JS; Hong J; Andrée BA; Gulyás B; Farde L; Innis RB; Pike VW; Halldin C
    Mol Imaging Biol; 2009; 11(1):23-30. PubMed ID: 18800204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and positron emission tomography evaluation of three norepinephrine transporter radioligands: [C-11]desipramine, [C-11]talopram and [C-11]talsupram.
    Schou M; Sóvágó J; Pike VW; Gulyás B; Bøgesø KP; Farde L; Halldin C
    Mol Imaging Biol; 2006; 8(1):1-8. PubMed ID: 16322935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain.
    Schou M; Halldin C; Sóvágó J; Pike VW; Hall H; Gulyás B; Mozley PD; Dobson D; Shchukin E; Innis RB; Farde L
    Synapse; 2004 Aug; 53(2):57-67. PubMed ID: 15170818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography.
    Jarkas N; McConathy J; Votaw JR; Voll RJ; Malveaux E; Camp VM; Williams L; Goodman RR; Kilts CD; Goodman MM
    Nucl Med Biol; 2005 Jan; 32(1):75-86. PubMed ID: 15691664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
    Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L
    Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling.
    Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Farde L; Ginovart N; Luthra SK; Gunn RN; Bench CJ; Sargent PA; Grasby PM
    Nucl Med Biol; 1998 Apr; 25(3):215-23. PubMed ID: 9620626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of norepinephrine transporter in the human brain using PET with (S,S)-18F-FMeNER-D2.
    Arakawa R; Okumura M; Ito H; Seki C; Takahashi H; Takano H; Nakao R; Suzuki K; Okubo Y; Halldin C; Suhara T
    J Nucl Med; 2008 Aug; 49(8):1270-6. PubMed ID: 18632811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2.
    Seneca N; Gulyás B; Varrone A; Schou M; Airaksinen A; Tauscher J; Vandenhende F; Kielbasa W; Farde L; Innis RB; Halldin C
    Psychopharmacology (Berl); 2006 Sep; 188(1):119-27. PubMed ID: 16896954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET Quantification of the Norepinephrine Transporter in Human Brain with (
    Moriguchi S; Kimura Y; Ichise M; Arakawa R; Takano H; Seki C; Ikoma Y; Takahata K; Nagashima T; Yamada M; Mimura M; Suhara T
    J Nucl Med; 2017 Jul; 58(7):1140-1145. PubMed ID: 27980046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET.
    Osman S; Lundkvist C; Pike VW; Halldin C; McCarron JA; Swahn CG; Ginovart N; Luthra SK; Bench CJ; Grasby PM; Wikström H; Barf T; Cliffe IA; Fletcher A; Farde L
    Nucl Med Biol; 1996 Jul; 23(5):627-34. PubMed ID: 8905828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a new norepinephrine transporter PET ligand in baboons, both in brain and peripheral organs.
    Ding YS; Lin KS; Garza V; Carter P; Alexoff D; Logan J; Shea C; Xu Y; King P
    Synapse; 2003 Dec; 50(4):345-52. PubMed ID: 14556239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific in vivo binding to the norepinephrine transporter demonstrated with the PET radioligand, (S,S)-[11C]MeNER.
    Schou M; Halldin C; Sóvágó J; Pike VW; Gulyás B; Mozley PD; Johnson DP; Hall H; Innis RB; Farde L
    Nucl Med Biol; 2003 Oct; 30(7):707-14. PubMed ID: 14499328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vivo evaluation of novel radiotracers for the in vivo imaging of the norepinephrine transporter.
    Wilson AA; Johnson DP; Mozley D; Hussey D; Ginovart N; Nobrega J; Garcia A; Meyer J; Houle S
    Nucl Med Biol; 2003 Feb; 30(2):85-92. PubMed ID: 12623106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey.
    Sandell J; Halldin C; Pike VW; Chou YH; Varnäs K; Hall H; Marchais S; Nowicki B; Wikström HV; Swahn CG; Farde L
    Nucl Med Biol; 2001 Feb; 28(2):177-85. PubMed ID: 11295428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluations of norepinephrine transporter radioligands with reference tissue models in rhesus monkeys: (S,S)-[18F]FMeNER-D2 and (S,S)-[11C]MeNER.
    Takano A; Gulyás B; Varrone A; Halldin C
    Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1885-91. PubMed ID: 19565240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of [¹⁸F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO-B).
    Nag S; Lehmann L; Kettschau G; Heinrich T; Thiele A; Varrone A; Gulyas B; Halldin C
    Bioorg Med Chem; 2012 May; 20(9):3065-71. PubMed ID: 22436387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain.
    Pierson ME; Andersson J; Nyberg S; McCarthy DJ; Finnema SJ; Varnäs K; Takano A; Karlsson P; Gulyás B; Medd AM; Lee CM; Powell ME; Heys JR; Potts W; Seneca N; Mrzljak L; Farde L; Halldin C
    Neuroimage; 2008 Jul; 41(3):1075-85. PubMed ID: 18434202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.
    Shiue GG; Choi SR; Fang P; Hou C; Acton PD; Cardi C; Saffer JR; Greenberg JH; Karp JS; Kung HF; Shiue CY
    J Nucl Med; 2003 Dec; 44(12):1890-7. PubMed ID: 14660713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon-11 HOMADAM: a novel PET radiotracer for imaging serotonin transporters.
    Jarkas N; Votaw JR; Voll RJ; Williams L; Camp VM; Owens MJ; Purselle DC; Bremner JD; Kilts CD; Nemeroff CB; Goodman MM
    Nucl Med Biol; 2005 Apr; 32(3):211-24. PubMed ID: 15820756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.